iSpecimen Inc. offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company's iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. The Company, as an AI agent identifies disease-associated proteins and an AI model that predicts and monitors disease trends.
Company Information
About this company
Key people
Key facts
- Shares in issue2.52m
- EPICISPC
- ISINUS45032V3069
- LocationUnited States
- SectorTechnology
- IndustrySoftware & Programming
- Market cap$2.05m
- Employees7
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.